Selected research
Market Structure
Global Lung Cancer Screening Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Lung Cancer Screening Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Lung Cancer Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Lung Cancer Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Lung Cancer Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Lung Cancer Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Lung Cancer Screening Software include Siemens Healthineers, GE HealthCare, Philips Healthcare, Canon Medical Systems, United Imaging Healthcare, InferVision, Airdoc, VUNO and Lunit, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Lung Cancer Screening Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Lung Cancer Screening Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Lung Cancer Screening Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Lung Cancer Screening Software market size, projected growth trends, production technologies, key applications, and end-use industries.
Lung Cancer Screening Software Segment by Company
Siemens Healthineers
GE HealthCare
Philips Healthcare
Canon Medical Systems
United Imaging Healthcare
InferVision
Airdoc
VUNO
Lunit
Qure.ai
Riverain Technologies
Zebra Medical Vision
Arterys
Deepwise
EverFortune AI
Lung Cancer Screening Software Segment by Type
Cloud-Based
Web-Based
Lung Cancer Screening Software Segment by Application
Hospitals
Medical Examination Institutions
Public Health Screening
Others
Lung Cancer Screening Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lung Cancer Screening Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lung Cancer Screening Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lung Cancer Screening Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Lung Cancer Screening Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lung Cancer Screening Software industry.
Chapter 3: Detailed analysis of Lung Cancer Screening Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lung Cancer Screening Softwarerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-Based
- Web-Based
Applications
- Hospitals
- Medical Examination Institutions
- Public Health Screening
- Others
Companies covered
- Siemens Healthineers
- GE HealthCare
- Philips Healthcare
- Canon Medical Systems
- United Imaging Healthcare
- InferVision
- Airdoc
- VUNO
- Lunit
- Qure.ai
- Riverain Technologies
- Zebra Medical Vision
- Arterys
- Deepwise
- EverFortune AI
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Lung Cancer Screening Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Cloud-Based
- 1.2.3 Web-Based
- 1.3 Market Analysis by Application
- 1.3.1 Global Lung Cancer Screening Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Medical Examination Institutions
- 1.3.4 Public Health Screening
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Lung Cancer Screening Software Growth Trends by Region
- 1.5.1 Global Lung Cancer Screening Software Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Lung Cancer Screening Software Market Size by Region (2021-2026)
- 1.5.3 Lung Cancer Screening Software Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Lung Cancer Screening Software Market Dynamics
- 2.1 Lung Cancer Screening Software Industry Trends
- 2.2 Lung Cancer Screening Software Industry Drivers
- 2.3 Lung Cancer Screening Software Industry Opportunities and Challenges
- 2.4 Lung Cancer Screening Software Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Lung Cancer Screening Software Revenue by Company (2021-2026)
- 3.2 Global Lung Cancer Screening Software Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Lung Cancer Screening Software Key Company Head office and Area Served
- 3.4 Global Lung Cancer Screening Software Company, Product Type & Application
- 3.5 Global Lung Cancer Screening Software Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Lung Cancer Screening Software Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Lung Cancer Screening Software Players Market Share by Revenue in 2025
- 3.6.3 2025 Lung Cancer Screening Software Tier 1, Tier 2, and Tier 3
4 Lung Cancer Screening Software Market by Type
- 4.1 Global Lung Cancer Screening Software Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Lung Cancer Screening Software Market Size by Type (2021-2032)
- 4.3 Global Lung Cancer Screening Software Market Size Share by Type (2021-2032)
5 Lung Cancer Screening Software Market by Application
- 5.1 Global Lung Cancer Screening Software Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Lung Cancer Screening Software Market Size by Application (2021-2032)
- 5.3 Global Lung Cancer Screening Software Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Siemens Healthineers
- 6.1.1 Siemens Healthineers Company Information
- 6.1.2 Siemens Healthineers Business Overview
- 6.1.3 Siemens Healthineers Lung Cancer Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Siemens Healthineers Lung Cancer Screening Software Product Portfolio
- 6.1.5 Siemens Healthineers Recent Developments
- 6.2 GE HealthCare
- 6.2.1 GE HealthCare Company Information
- 6.2.2 GE HealthCare Business Overview
- 6.2.3 GE HealthCare Lung Cancer Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 GE HealthCare Lung Cancer Screening Software Product Portfolio
- 6.2.5 GE HealthCare Recent Developments
- 6.3 Philips Healthcare
- 6.3.1 Philips Healthcare Company Information
- 6.3.2 Philips Healthcare Business Overview
- 6.3.3 Philips Healthcare Lung Cancer Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Philips Healthcare Lung Cancer Screening Software Product Portfolio
- 6.3.5 Philips Healthcare Recent Developments
- 6.4 Canon Medical Systems
- 6.4.1 Canon Medical Systems Company Information
- 6.4.2 Canon Medical Systems Business Overview
- 6.4.3 Canon Medical Systems Lung Cancer Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Canon Medical Systems Lung Cancer Screening Software Product Portfolio
- 6.4.5 Canon Medical Systems Recent Developments
- 6.5 United Imaging Healthcare
- 6.5.1 United Imaging Healthcare Company Information
- 6.5.2 United Imaging Healthcare Business Overview
- 6.5.3 United Imaging Healthcare Lung Cancer Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 United Imaging Healthcare Lung Cancer Screening Software Product Portfolio
- 6.5.5 United Imaging Healthcare Recent Developments
- 6.6 InferVision
- 6.6.1 InferVision Company Information
- 6.6.2 InferVision Business Overview
- 6.6.3 InferVision Lung Cancer Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 InferVision Lung Cancer Screening Software Product Portfolio
- 6.6.5 InferVision Recent Developments
- 6.7 Airdoc
- 6.7.1 Airdoc Company Information
- 6.7.2 Airdoc Business Overview
- 6.7.3 Airdoc Lung Cancer Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Airdoc Lung Cancer Screening Software Product Portfolio
- 6.7.5 Airdoc Recent Developments
- 6.8 VUNO
- 6.8.1 VUNO Company Information
- 6.8.2 VUNO Business Overview
- 6.8.3 VUNO Lung Cancer Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 VUNO Lung Cancer Screening Software Product Portfolio
- 6.8.5 VUNO Recent Developments
- 6.9 Lunit
- 6.9.1 Lunit Company Information
- 6.9.2 Lunit Business Overview
- 6.9.3 Lunit Lung Cancer Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Lunit Lung Cancer Screening Software Product Portfolio
- 6.9.5 Lunit Recent Developments
- 6.10 Qure.ai
- 6.10.1 Qure.ai Company Information
- 6.10.2 Qure.ai Business Overview
- 6.10.3 Qure.ai Lung Cancer Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Qure.ai Lung Cancer Screening Software Product Portfolio
- 6.10.5 Qure.ai Recent Developments
- 6.11 Riverain Technologies
- 6.11.1 Riverain Technologies Company Information
- 6.11.2 Riverain Technologies Business Overview
- 6.11.3 Riverain Technologies Lung Cancer Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Riverain Technologies Lung Cancer Screening Software Product Portfolio
- 6.11.5 Riverain Technologies Recent Developments
- 6.12 Zebra Medical Vision
- 6.12.1 Zebra Medical Vision Company Information
- 6.12.2 Zebra Medical Vision Business Overview
- 6.12.3 Zebra Medical Vision Lung Cancer Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Zebra Medical Vision Lung Cancer Screening Software Product Portfolio
- 6.12.5 Zebra Medical Vision Recent Developments
- 6.13 Arterys
- 6.13.1 Arterys Company Information
- 6.13.2 Arterys Business Overview
- 6.13.3 Arterys Lung Cancer Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Arterys Lung Cancer Screening Software Product Portfolio
- 6.13.5 Arterys Recent Developments
- 6.14 Deepwise
- 6.14.1 Deepwise Company Information
- 6.14.2 Deepwise Business Overview
- 6.14.3 Deepwise Lung Cancer Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Deepwise Lung Cancer Screening Software Product Portfolio
- 6.14.5 Deepwise Recent Developments
- 6.15 EverFortune AI
- 6.15.1 EverFortune AI Company Information
- 6.15.2 EverFortune AI Business Overview
- 6.15.3 EverFortune AI Lung Cancer Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 EverFortune AI Lung Cancer Screening Software Product Portfolio
- 6.15.5 EverFortune AI Recent Developments
7 North America
- 7.1 North America Lung Cancer Screening Software Market Size (2021-2032)
- 7.2 North America Lung Cancer Screening Software Market Size by Type
- 7.2.1 North America Lung Cancer Screening Software Market Size by Type (2021-2026)
- 7.2.2 North America Lung Cancer Screening Software Market Size by Type (2027-2032)
- 7.2.3 North America Lung Cancer Screening Software Market Share by Type (2021-2032)
- 7.3 North America Lung Cancer Screening Software Market Size by Application
- 7.3.1 North America Lung Cancer Screening Software Market Size by Application (2021-2026)
- 7.3.2 North America Lung Cancer Screening Software Market Size by Application (2027-2032)
- 7.3.3 North America Lung Cancer Screening Software Market Share by Application (2021-2032)
- 7.4 North America Lung Cancer Screening Software Market Size by Country
- 7.4.1 North America Lung Cancer Screening Software Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Lung Cancer Screening Software Market Size by Country (2021-2026)
- 7.4.3 North America Lung Cancer Screening Software Market Size by Country (2027-2032)
- 7.4.4 North America Lung Cancer Screening Software Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Lung Cancer Screening Software Market Size (2021-2032)
- 8.2 Europe Lung Cancer Screening Software Market Size by Type
- 8.2.1 Europe Lung Cancer Screening Software Market Size by Type (2021-2026)
- 8.2.2 Europe Lung Cancer Screening Software Market Size by Type (2027-2032)
- 8.2.3 Europe Lung Cancer Screening Software Market Share by Type (2021-2032)
- 8.3 Europe Lung Cancer Screening Software Market Size by Application
- 8.3.1 Europe Lung Cancer Screening Software Market Size by Application (2021-2026)
- 8.3.2 Europe Lung Cancer Screening Software Market Size by Application (2027-2032)
- 8.3.3 Europe Lung Cancer Screening Software Market Share by Application (2021-2032)
- 8.4 Europe Lung Cancer Screening Software Market Size by Country
- 8.4.1 Europe Lung Cancer Screening Software Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Lung Cancer Screening Software Market Size by Country (2021-2026)
- 8.4.3 Europe Lung Cancer Screening Software Market Size by Country (2027-2032)
- 8.4.4 Europe Lung Cancer Screening Software Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Lung Cancer Screening Software Market Size (2021-2032)
- 9.2 China Lung Cancer Screening Software Market Size by Type
- 9.2.1 China Lung Cancer Screening Software Market Size by Type (2021-2026)
- 9.2.2 China Lung Cancer Screening Software Market Size by Type (2027-2032)
- 9.2.3 China Lung Cancer Screening Software Market Share by Type (2021-2032)
- 9.3 China Lung Cancer Screening Software Market Size by Application
- 9.3.1 China Lung Cancer Screening Software Market Size by Application (2021-2026)
- 9.3.2 China Lung Cancer Screening Software Market Size by Application (2027-2032)
- 9.3.3 China Lung Cancer Screening Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Lung Cancer Screening Software Market Size (2021-2032)
- 10.2 Asia Lung Cancer Screening Software Market Size by Type
- 10.2.1 Asia Lung Cancer Screening Software Market Size by Type (2021-2026)
- 10.2.2 Asia Lung Cancer Screening Software Market Size by Type (2027-2032)
- 10.2.3 Asia Lung Cancer Screening Software Market Share by Type (2021-2032)
- 10.3 Asia Lung Cancer Screening Software Market Size by Application
- 10.3.1 Asia Lung Cancer Screening Software Market Size by Application (2021-2026)
- 10.3.2 Asia Lung Cancer Screening Software Market Size by Application (2027-2032)
- 10.3.3 Asia Lung Cancer Screening Software Market Share by Application (2021-2032)
- 10.4 Asia Lung Cancer Screening Software Market Size by Country
- 10.4.1 Asia Lung Cancer Screening Software Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Lung Cancer Screening Software Market Size by Country (2021-2026)
- 10.4.3 Asia Lung Cancer Screening Software Market Size by Country (2027-2032)
- 10.4.4 Asia Lung Cancer Screening Software Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Lung Cancer Screening Software Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Lung Cancer Screening Software Market Size by Type
- 11.2.1 South America, Middle East & Africa Lung Cancer Screening Software Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Lung Cancer Screening Software Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Lung Cancer Screening Software Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Lung Cancer Screening Software Market Size by Application
- 11.3.1 South America, Middle East & Africa Lung Cancer Screening Software Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Lung Cancer Screening Software Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Lung Cancer Screening Software Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Lung Cancer Screening Software Market Size by Country
- 11.4.1 South America, Middle East & Africa Lung Cancer Screening Software Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Lung Cancer Screening Software Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Lung Cancer Screening Software Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Lung Cancer Screening Software Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst